339 related articles for article (PubMed ID: 7703228)
1. delta 22-Ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism.
Setchell KD; Yamashita H; Rodrigues CM; O'Connell NC; Kren BT; Steer CJ
Biochemistry; 1995 Apr; 34(13):4169-78. PubMed ID: 7703228
[TBL] [Abstract][Full Text] [Related]
2. Formation of delta 22-bile acids in rats is not gender specific and occurs in the peroxisome.
Rodrigues CM; Kren BT; Steer CJ; Setchell KD
J Lipid Res; 1996 Mar; 37(3):540-50. PubMed ID: 8728317
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
Purucker E; Marschall HU; Winograd R; Matern S
Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121
[TBL] [Abstract][Full Text] [Related]
4. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids.
Yang T; Shu T; Liu G; Mei H; Zhu X; Huang X; Zhang L; Jiang Z
J Steroid Biochem Mol Biol; 2017 Sep; 172():69-78. PubMed ID: 28583875
[TBL] [Abstract][Full Text] [Related]
5. Effects of ursodeoxycholic acid, analogues of ursodeoxycholic acid and combination of bile acids on bile acid synthesis in cultured rat hepatocytes.
Kubaska WM; Gurley EC; Hylemon PB; Heuman DM; Mosbach EH; Vlahcevic ZR
Biochim Biophys Acta; 1987 Aug; 920(3):195-204. PubMed ID: 3607077
[TBL] [Abstract][Full Text] [Related]
6. Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps.
Batta AK; Salen G; Holubec H; Brasitus TA; Alberts D; Earnest DL
Cancer Res; 1998 Apr; 58(8):1684-7. PubMed ID: 9563483
[TBL] [Abstract][Full Text] [Related]
7. Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man.
Beuers U; Fischer S; Spengler U; Paumgartner G
J Hepatol; 1991 Jul; 13(1):97-103. PubMed ID: 1918882
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular bile acid transport and ursodeoxycholic acid hypercholeresis.
Scharschmidt BF; Lake JR
Dig Dis Sci; 1989 Dec; 34(12 Suppl):5S-15S. PubMed ID: 2689116
[TBL] [Abstract][Full Text] [Related]
9. Bile acids with a cyclopropyl-containing side chain. IV. Physicochemical and biological properties of the four diastereoisomers of 3 alpha,7 beta-dihydroxy-22,23-methylene-5 beta-cholan-24-oic acid.
Roda A; Grigolo B; Aldini R; Simoni P; Pellicciari R; Natalini B; Balducci R
J Lipid Res; 1987 Dec; 28(12):1384-97. PubMed ID: 3430066
[TBL] [Abstract][Full Text] [Related]
10. 5 beta-hydroxylation by the liver. Identification of 3,5,7-trihydroxy nor-bile acids as new major biotransformation products of 3,7-dihydroxy nor-bile acids in rodents.
Schteingart CD; Hagey LR; Setchell KD; Hofmann AF
J Biol Chem; 1993 May; 268(15):11239-46. PubMed ID: 8496179
[TBL] [Abstract][Full Text] [Related]
11. A new amino acid derivative of ursodeoxycholate, (N-L-Glutamyl)-UDCA (UDCA-Glu), to selectively release UDCA in the colon.
Asciutti S; Castellani D; Nardi E; Morelli O; Clementi M; Chistolini F; Gentili G; Setchell KD; O'Connell N; Pellicciari R; Clerici C
Anticancer Res; 2009 Dec; 29(12):4971-9. PubMed ID: 20044604
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and metabolism of [14C]ursodeoxycholic acid in the rat.
Parquet M; Rey C; Groussard M; Infante R
Biochim Biophys Acta; 1981 Aug; 665(2):299-305. PubMed ID: 7284427
[TBL] [Abstract][Full Text] [Related]
13. Conjugation with taurine prevents side-chain desaturation of ursodeoxycholic and beta-muricholic acids in bile fistula rats.
Guitaoui M; Parquet M; Aubert C; Montet AM; Montet JC
Fundam Clin Pharmacol; 2004 Aug; 18(4):457-64. PubMed ID: 15312152
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.
Ward JBJ; Lajczak NK; Kelly OB; O'Dwyer AM; Giddam AK; Ní Gabhann J; Franco P; Tambuwala MM; Jefferies CA; Keely S; Roda A; Keely SJ
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G550-G558. PubMed ID: 28360029
[No Abstract] [Full Text] [Related]
15. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids.
Zollner G; Wagner M; Moustafa T; Fickert P; Silbert D; Gumhold J; Fuchsbichler A; Halilbasic E; Denk H; Marschall HU; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G923-32. PubMed ID: 16357057
[TBL] [Abstract][Full Text] [Related]
16. New 6-substituted bile acids: physico-chemical and biological properties of 6 alpha-methyl ursodeoxycholic acid and 6 alpha-methyl-7-epicholic acid.
Roda A; Pellicciari R; Cerrè C; Polimeni C; Sadeghpour B; Marinozzi M; Forti GC; Sapigni E
J Lipid Res; 1994 Dec; 35(12):2268-79. PubMed ID: 7897324
[TBL] [Abstract][Full Text] [Related]
17. Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.
Marschall HU; Matern H; Wietholtz H; Egestad B; Matern S; Sjövall J
J Clin Invest; 1992 Jun; 89(6):1981-7. PubMed ID: 1602004
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
Nakagawa M; Colombo C; Setchell KD
Hepatology; 1990 Aug; 12(2):322-34. PubMed ID: 2391071
[TBL] [Abstract][Full Text] [Related]
19. Bile acid conjugation in early stage cholestatic liver disease before and during treatment with ursodeoxycholic acid.
Fracchia M; Setchell KD; Crosignani A; Podda M; O'Connell N; Ferraris R; Hofmann AF; Galatola G
Clin Chim Acta; 1996 Apr; 248(2):175-85. PubMed ID: 8740581
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease.
Colombo C; Crosignani A; Alicandro G; Zhang W; Biffi A; Motta V; Corti F; Setchell KDR
J Pediatr; 2016 Oct; 177():59-65.e1. PubMed ID: 27297203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
